Anorexia nervosa: A role for L-arginine supplementation in cardiovascular risk factors?

International Journal of Eating Disorders

Volumn 43, Issue 5, 2010, Pages 464-471

  Vignini, Arianna ^a   D'Angelo, Monica ^a   Nanetti, Laura ^a   Camilloni, Maria Angela ^a   Cester, Anna Maria ^a   Faloia, Emanuela ^a   Salvolini, Eleonora ^a   Mazzanti, Laura ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Ca2 i; Anorexia nervosa; Concentration; CVD; L arginine NO pathway; Platelets

Indexed keywords

ARGININE; CALCIUM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ABSENCE OF SIDE EFFECTS; ADULT; ANOREXIA NERVOSA; ARTICLE; BLOOD ANALYSIS; CALCIUM CELL LEVEL; CARDIOVASCULAR RISK; CELL LYSATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN CELL; MALE; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; WESTERN BLOTTING;

ADULT; ANALYSIS OF VARIANCE; ANOREXIA NERVOSA; ARGININE; BLOTTING, WESTERN; CALCIUM; CARDIOVASCULAR SYSTEM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RISK FACTORS;

EID: 77953191309     PISSN: 02763478     EISSN: 1098108X     Source Type: Journal    
DOI: 10.1002/eat.20709     Document Type: Article

References (58)

1. Kishi T, Elmquist JK. Body weight is regulated by the brain: A link between feeding and emotion. Mol Psychiatr 2005;10: 132-146.
2. Steinhausen HC. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry 2002;159:1284-1294.
3. Probst M, Goris M, Vandereycken W, Van Coppenolle H. Body composition in female anorexia nervosa patients. Br J Nutr 1996;76:639-647. (Pubitemid 26395292)
4. McDermott BM, Jaffa T. Eating disorders in children and adolescents: An update. Curr Opin Psychiatr 2005;18:407-410. (Pubitemid 40834963)
5. Moyano D, Vilaseca MA, Artuch R, Lambruschini N. Plasma amino acids in anorexia nervosa. Eur J Clin Nutr 1998;52: 684-689. (Pubitemid 28433130)
6. Wu G, Meininger CJ, Knabe DA, Bazer FW, Rhoads JM. Arginine nutrition in development, health and disease. Curr Opin Clin Nutr Metab Care 2000;3:59-66.
7. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
8. Förstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994; 23:1121-1131.
9. Suzuki E, Mizushima H, Ono Y, Yokoyama M, Miyaoka H. Plasma nitrate and nitrite levels of patients with eating disorders. Psychiatry Clin Neurosci 2003;57:343-344. (Pubitemid 36644424)
10. Stefano GB, Ottaviani E. The biochemical substrate of nitric oxide signaling is present in primitive non-cognitive organisms. Brain Res 2002;924:82-89. (Pubitemid 34017467)
11. Esch T, Stefano GB, Fricchione GL, Benson H. Stress related disease - A potential role for nitric oxide. Med Sci Monit 2002;8: 103-118.
12. Wilding JPH. Neuropeptides and appetite control. Diabet Med 2002;19:619-627.
13. Brunini TM, da Silva CD, Siqueira MA, Moss MB, Santos SF, Mendes-Ribeiro AC. Uremia, atherothrombosis and malnutrition: The role of L-arginine-nitric oxide pathway. Cardiovasc Hematol Disord Drug Targets 2006;6:133-140.
14. Vannacci A, Ravaldi C, Giannini L, Rotella CM, Masini E, Faravelli C, et al. Increased nitric oxide production in eating disorders. Neurosci Lett 2006;399:230-233.
15. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 1991;83:1057-1062.
16. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994;89:2176-2182.
17. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992;90:1168-1172.
18. Wang BY, Candipan RC, Arjomandi M, Hsiun PT, Tsao PS, Cooke JP. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol 1996;28:1573-1579. (Pubitemid 26391866)
19. Jang JJ, Ho HK, Kwan HH, Fajardo LF, Cooke JP. Angiogenesis is impaired by hypercholesterolemia: Role of asymmetric dimethylarginine. Circulation 2000;102:1414-1419.
20. Bode-Boger SM, Boger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A, et al. L-Arginine induces nitric oxide- dependent vasodilation in patients with critical limb ischemia: A randomized, controlled study. Circulation 1996;93:85-90.
21. Sharp CW, Freeman CP. The medical complications of anorexia nervosa. Br J Psychiatry 1993;162:452-462.
22. Mehler PS, Krantz M. Anorexia nervosa medical issues. J Womens Health (Larchmt) 2003;12:331-340.
23. Matzkin V, Slobodianik N, Pallaro A, Bello M, Geissler C. Risk factors for cardiovascular disease in patients with anorexia nervosa. Int J Psychiatr Nurs Res 2007;13:1531-1545.
24. Chen L, Mehta JL. Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets. J Cardiovasc Pharmacol 1996;27:154-158. (Pubitemid 26010653)
25. American Psychiatric Association. DSM-IV Diagnostic and Statistical Manual of Mental Disorder,4th ed. Washington, DC; American Psychiatric Association, 1994.
26. Rao GHR. Measurement of ionized calcium in normal human blood platelets. Anal Biochem 1988;169:400-404.
27. Vignini A, Nanetti L, Moroni C, Tanase L, Bartolini M, Luzzi S, et al. Modifications of platelet from Alzheimer disease patients: A possible relation between membrane properties and NO metabolites. Neurobiol Aging 2007;28:987-994.
28. Bradford M. A rapid and sensitive Method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
29. Camilletti A, Moretti N, Giacchetti G, Faloia E, Martarelli D, Mantero F, et al. Decreased nitric oxide levels and increased calcium content in platelets of hypertensive patients. Am J Hypertens 2001;14:382-386. (Pubitemid 32337144)
30. Ferretti G, Rabini RA, Bacchetti T, Vignini A, Salvolini E, Ravaglia F, et al. Glycated low density lipoproteins modify platelet properties: A compositional and functional study. J Clin Endocrinol Metab 2002;87:2180-2184.
31. Mora RJF. Malnutrition: Organic and functional consequences. World J Surg 1999;23:530-535.
32. Golden MH, Waterlow JC, Picou D. Protein turnover, synthesis and breakdown before and after recovery from protein energy malnutrition. Clin Sci Mol Med 1977;53:473-477. (Pubitemid 8209012)
33. Casper Regina C. Carbohydrate metabolism and its regulatory hormones in anorexia nervosa. Psychiatr Res 1996;62:85-96.
34. Moyano D, Sierra C, Brandi N, Artuch R, Mira A, García-Tornel S, et al. Antioxidant status in anorexia nervosa. Int J Eat Disord 1999;25:99-103.
35. Pomeroy C, Eckert E, Hu S, Eiken B, Mentink M, Crosby RD, et al. Role of interleukine-6 and transforming growth factor-α in anorexia nervosa. Soc Biol Psychiatry 1994;36:836-839.
36. Nakai Y, Hamagaki S, Tagaki R, Taniguchi A, Kurimoto F. Plasma concentrations of tumor necrosis factor α (TNFα) and soluble TNFa receptors in patients with anorexia nervosa. J Clin Endocrinol Metab 1999;84:1226-1228. (Pubitemid 30644380)
37. Goldberg ND, Haddox MK, Nicol SE, Glass DB, Sanford CH, Kuehl FA Jr, et al. Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: The Yin Yang hypothesis. Adv Cyclic Nucleotide Res 1975;5:307-330.
38. Krantz MJ, Donahoo WT, Melanson EL, Mehler PS. QT interval dispersion and resting metabolic rate in chronic anorexia nervosa. Int J Eat Disord 2005;37:166-170. (Pubitemid 40365698)
39. Lind DS. Arginine and cancer. J Nutr 2004;134:2837S-2841S.
40. Wilmore D. Enteral and parenteral arginine supplementation to improve medical outcomes in hospitalized patients. J Nutr 2004;134:2863S-2867S.
41. Paddon-Jones D, Borsheim E, Wolfe RR. Potential ergogenic effects of arginine and creatine supplementation. J Nutr 2004; 134:2888S-2894S.
42. Appleton J. Arginine: Clinical potential of a semi-essential amino. Altern Med Rev 2002;7:512-522.
43. Rigaud D, Tallonneau I, Vergès B. Hypercholesterolaemia in anorexia nervosa: Frequency and changes during refeeding. Diabetes Metab 2009;35:57-63.
44. Nova E, Lopez-Vidriero I, Varela P, Casas J, Marcos A. Evolution of serum biochemical indicators in anorexia nervosa patients: A 1-year follow-up study. J Hum Nutr Diet 2008;21: 23-30.
45. Ohwada R, Hotta M, Oikawa S, Takano K. Etiology of hypercholesterolemia in patients with anorexia nervosa. Int J Eat Disord 2006;39:598-601. (Pubitemid 44621815)
46. Matzkin VB, Geissler C, Coniglio R, Selles J, Bello M. Cholesterol concentrations in patients with Anorexia Nervosa and in healthy controls. Int J Psychiatr Nurs Res 2006;11:1283-1293.
47. Curatola G, Camilloni MA, Vignini A, Nanetti L, Boscaro M, Mazzanti L. Chemical-physical properties of lipoproteins in anorexia nervosa. Eur J Clin Invest 2004;34:747-751. (Pubitemid 39524299)
48. Laroia ST, Ganti AK, Laroia AT, Tendulkar KK. Endothelium and the lipid metabolism: The current understanding. Int J Cardiol 2003;88:1-9. (Pubitemid 36351402)
49. Radomski MW, Palmer RM, Moncada S. Characterization of the L-arginine: Nitric oxide pathway in human platelets. J Pharmacol 1990;101:325-328. (Pubitemid 20292885)
50. Evans RW, Fernstrom JD, Thompson J, Morris SM, Kuller LH. Biochemical responses of healthy subjects during dietary supplementation with L-arginine. J Nutr Biochem 2004;15: 534-539. (Pubitemid 39209396)
51. Castillo L, deRojas TC, Chapman TE, Vogt J, Burke JF, Tannenbaum SR, et al. Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc Natl Acad Sci USA 1993;90:193-197.
52. 15N-labeled nitrate by gas chromatographymass spectrometry. Nitric Oxide 2004; 11:1-8.
53. Loscalzo J. L-arginine and atherothrombosis. J Nutr 2004;134: 2798-2800.
54. Preli RB, Klein KP, Herrington DM. Vascular effects of dietary L-arginine supplementation. Atherosclerosis 2002;162:1-15.
55. Wolf A, Zalpour C, Theilmeier G, Wang BY, Ma A, Anderson B, et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol 1997;29:479-485. (Pubitemid 27116086)
56. Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, et al. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients. Am J Physiol Endocrinol Metab 2006;291:906-912.
57. Böger RH. L-Arginine therapy in cardiovascular pathologies: Beneficial or dangerous? Curr Opin Clin Nutr Metab Care 2008;11:55-61.
58. Shao A, Hathcock JN. Risk assessment for the amino acids taurine, L-glutamine and L-arginine. Regul Toxicol Pharmacol 2008;50:376-399.